Home NDC 80203-347 Enjaymo
Product NDC 80203-347
11-digit product format 802030347
Labeler code 80203
Product ID 80203-347_6b1f36e8-41c9-4d12-b265-49c9d819c58b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sutimlimab-jome
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler Bioverativ U.S. LLC.
Application BLA761164
Marketing category BLA
Marketing start 2022-02-04
Marketing end 0000-00-00
Substance SUTIMLIMAB
Active strength 50 mg/mL
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 80203-347-01 Enjaymo 22 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION, CONCENTRATE 22 10 80203-347-01 Enjaymo 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 80203-347 ENJAYMO (SUTIMLIMAB-JOME) INJECTION, SOLUTION, CONCENTRATE [BIOVERATIV THERAPEUTICS INC.] 10 Legacy NDC, 2 package rows 20240511_281cf1d4-6296-4416-858e-9bff46d01b71.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Enjaymo SUTIMLIMAB-JOME Recordati Rare Diseases, Inc. 0a25363a-7781-d9f8-cb1c-be22987bf03b 2026-03-02 Warnings, Adverse reactions Exact identifier application number: BLA761164
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761164 Enjaymo sutimlimab-jome 351(a) Rx 2026-08-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 80203-347-01 80203034701 1 VIAL, SINGLE-DOSE in 1 CARTON (80203-347-01) > 22 mL in 1 VIAL, SINGLE-DOSE 2022-02-04 0000-00-00 No No Current